Suppr超能文献

造血干细胞移植后需要重症监护的儿童的预后变化。

Changing outcomes for children requiring intensive care following hematopoietic stem cell transplantation.

作者信息

Kache Saraswati, Weiss Irwin K, Moore Theodore B

机构信息

Division of Critical Care, Department of Paediatrics, David Geffen School of Medicin at UCLA, Los Angeles, CA 90095-1752, USA.

出版信息

Pediatr Transplant. 2006 May;10(3):299-303. doi: 10.1111/j.1399-3046.2005.00453.x.

Abstract

Past literature has shown that respiratory failure following hematopoietic stem cell transplant is associated with a universally poor outcome with mortality rates approaching 100%. More recent studies have suggested that patient survival is improving. We report our experience with the patients from our institution, a large children's hospital, who were admitted to the intensive care unit (ICU). Medical records of 183 patients, who received a bone marrow transplant between 1992 and early 2004, who were <20 yr of age, were retrospectively reviewed. Various factors that might influence mortality were examined. Over the course of the study, the ICU survival increased from 18% during the period 1992-1999 to 59% between 2000 and early 2004. In the latter period, 54% of the patients discharged from the ICU were alive at 100 days post-transplant. Factors that were significant predictors of poor outcome were malignancy as the reason for transplant, dialysis during the ICU stay, or extreme respiratory failure with a ratio of arterial oxygen tension (PaO2)/inspired oxygen concentration (FiO2) <300. Analysis of patients who required a high positive end-expiratory pressure or were ventilated with permissive hypercapnia showed that they also had a higher mortality. The impact on survival of factors such as age at time of transplant, graft-vs.-host disease, pneumonia, bacteremia, sepsis, post-transplant days, Pediatric Risk of Mortality III score, engraftment status, or veno-occlusive disease did not reach statistical significance in this cohort. Survival has improved for children who require intensive care following a bone marrow transplant, even for those who require mechanical ventilation. Patients with extreme respiratory failure and those requiring dialysis continue to have poor outcome. Because of an overall improvement in survival, children whose condition following transplant requires intensive care should be treated aggressively.

摘要

既往文献表明,造血干细胞移植后发生的呼吸衰竭普遍预后不良,死亡率接近100%。最近的研究提示患者生存率正在提高。我们报告了来自我们机构(一家大型儿童医院)入住重症监护病房(ICU)患者的情况。对1992年至2004年初接受骨髓移植、年龄<20岁的183例患者的病历进行了回顾性分析。研究了各种可能影响死亡率的因素。在研究过程中,ICU生存率从1992 - 1999年期间的18%增至2000年至2004年初的59%。在后一时期,从ICU出院的患者中有54%在移植后100天仍存活。移植的原因是恶性肿瘤、在ICU住院期间进行透析或动脉血氧分压(PaO2)/吸入氧浓度(FiO2)<300的严重呼吸衰竭是预后不良的显著预测因素。对需要高呼气末正压或采用允许性高碳酸血症通气的患者分析显示,他们的死亡率也较高。移植时的年龄、移植物抗宿主病、肺炎、菌血症、脓毒症、移植后天数、儿童死亡率风险Ⅲ评分、植入状态或静脉闭塞性疾病等因素对该队列患者生存的影响未达到统计学意义。骨髓移植后需要重症监护的儿童,即使是那些需要机械通气的儿童,生存率也有所提高。严重呼吸衰竭患者和需要透析的患者预后仍然较差。由于总体生存率有所提高,移植后病情需要重症监护的儿童应积极治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验